NCT00768625

Brief Summary

The purpose of this study is:

  1. 1.To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25)
  2. 2.To analyze the CPAP treatment over the clinical evolution of OSA patients
  3. 3.To determine if OSA is a independent predictor of cardiovascular risk

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

October 7, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

October 8, 2008

Status Verified

October 1, 2008

Enrollment Period

5.9 years

First QC Date

October 7, 2008

Last Update Submit

October 7, 2008

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular events

    five years

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1000 OSA patients and 1000 controls enrolled from Instituto do Sono database 500 subjects with body mass index less than 25

You may qualify if:

  • Men and women with OSA (apnea-hypopnea index higher than 5 events/hour)

You may not qualify if:

  • Body mass index higher than 40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto do Sono/AFIP

São Paulo, São Paulo, 04516001, Brazil

RECRUITING

Related Publications (3)

  • Feres MC, Fonseca FA, Cintra FD, Mello-Fujita L, de Souza AL, De Martino MC, Tufik S, Poyares D. An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP. Atherosclerosis. 2015 Aug;241(2):342-9. doi: 10.1016/j.atherosclerosis.2015.05.008. Epub 2015 May 23.

  • Cintra FD, Tufik S, Paola Ad, Feres MC, Melo-Fujita L, Oliveira W, Rizzi C, Poyares D. Cardiovascular profile in patients with obstructive sleep apnea. Arq Bras Cardiol. 2011 Apr;96(4):293-9. doi: 10.1590/s0066-782x2011005000030. Epub 2011 Mar 18. English, Portuguese, Spanish.

  • Rizzi CF, Cintra F, Risso T, Pulz C, Tufik S, de Paola A, Poyares D. Exercise capacity and obstructive sleep apnea in lean subjects. Chest. 2010 Jan;137(1):109-14. doi: 10.1378/chest.09-1201. Epub 2009 Oct 3.

MeSH Terms

Conditions

Sleep Apnea, ObstructiveObesity

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Fatima D Cintra, PhD

    Associacao Fundo de Incentivo a Psicofarmcologia

    PRINCIPAL INVESTIGATOR
  • Dalva Poyares, PhD

    Associacao Fundo de Incentivo a Psicofarmcologia

    STUDY CHAIR
  • Sergio Tufik, PhD

    Associacao Fundo de Incentivo a Psicofarmcologia

    STUDY DIRECTOR

Central Study Contacts

Fatima D Cintra, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 7, 2008

First Posted

October 8, 2008

Study Start

April 1, 2005

Primary Completion

March 1, 2011

Study Completion

December 1, 2012

Last Updated

October 8, 2008

Record last verified: 2008-10

Locations